000			02084 a2200589 4500
005			20250515194047.0
264		0	_c20100430
008			201004s 0 0 eng d
022			_a1432-1335
024	7		_a10.1007/s00432-009-0720-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aArtac, Mehmet
245	0	0	_aThe value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens. _h[electronic resource]
260			_bJournal of cancer research and clinical oncology _cJun 2010
300			_a803-9 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdenocarcinoma _xblood
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnalysis of Variance
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xblood
650	0	4	_aCamptothecin _xadministration & dosage
650	0	4	_aColorectal Neoplasms _xblood
650	0	4	_aDNA Repair _xdrug effects
650	0	4	_aDNA-Binding Proteins _xgenetics
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aIrinotecan
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aPredictive Value of Tests
650	0	4	_aProspective Studies
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
650	0	4	_aX-ray Repair Cross Complementing Protein 1
650	0	4	_aXeroderma Pigmentosum Group D Protein _xgenetics
700	1		_aBozcuk, Hakan
700	1		_aPehlivan, Sacide
700	1		_aAkcan, Songül
700	1		_aPehlivan, Mustafa
700	1		_aSever, Tugce
700	1		_aOzdogan, Mustafa
700	1		_aSavas, Burhan
773	0		_tJournal of cancer research and clinical oncology _gvol. 136 _gno. 6 _gp. 803-9
856	4	0	_uhttps://doi.org/10.1007/s00432-009-0720-3 _zAvailable from publisher's website
999			_c19294721 _d19294721